MARKET

PLX

PLX

Protalix Biother
AMEX
1.410
-0.070
-4.73%
After Hours: 1.400 -0.01 -0.71% 19:55 07/11 EDT
OPEN
1.460
PREV CLOSE
1.480
HIGH
1.470
LOW
1.410
VOLUME
1.01M
TURNOVER
--
52 WEEK HIGH
3.100
52 WEEK LOW
0.8214
MARKET CAP
112.25M
P/E (TTM)
57.09
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at PLX last week (0630-0704)?
Weekly Report · 6d ago
Protalix added to Russell 3000, Russell 2000 Indexes
TipRanks · 06/30 14:45
Weekly Report: what happened at PLX last week (0623-0627)?
Weekly Report · 06/30 11:17
Protalix BioTherapeutics Added to Russell 3000® and 2000 Indexes®
PR Newswire · 06/30 10:50
Protalix Holds Annual Stockholders Meeting in Tel Aviv
TipRanks · 06/26 21:00
Weekly Report: what happened at PLX last week (0616-0620)?
Weekly Report · 06/23 11:10
Weekly Report: what happened at PLX last week (0609-0613)?
Weekly Report · 06/16 11:17
Weekly Report: what happened at PLX last week (0602-0606)?
Weekly Report · 06/09 11:18
More
About PLX
Protalix BioTherapeutics, Inc. is a biopharmaceutical company. The Company is focused on the development and commercialization of recombinant therapeutic proteins expressed through its proprietary plant cell-based expression system, ProCellEx. In addition, the Company is developing PEGylated uricase, or PRX-115, for the treatment of uncontrolled gout, Long Acting (LA) DNase I, or PRX-119, for the treatment of NETs-related diseases, and other technologies and preclinical assets. Its ProCellEx platform is being used to manufacture both of its approved and marketed products as well as PRX-115 and PRX-119. PRX-115, a plant cell-expressed recombinant PEGylated Uricase (urate oxidase) - a chemically modified enzyme to treat uncontrolled gout. PRX-119 is a plant cell-expressed PEGylated recombinant human DNase I product candidate. Its product includes Elelyso and Elfabrio. Elelyso is an enzyme replacement therapy (ERT) for the treatment of patients with Gaucher disease.

Webull offers Protalix Biotherapeutics Inc stock information, including AMEX: PLX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, PLX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading PLX stock methods without spending real money on the virtual paper trading platform.